Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:97-102

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zieman, S. J.
Right arrow Articles by Hare, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zieman, S. J.
Right arrow Articles by Hare, J. M.
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Physiological and pathological control of gene expression
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2001;88:97.)
© 2001 American Heart Association, Inc.


Integrative Physiology

Upregulation of the Nitric Oxide–cGMP Pathway in Aged Myocardium

Physiological Response to l-Arginine

Susan J. Zieman, Gary Gerstenblith, Edward G. Lakatta, Gisele O. Rosas, Koenraad Vandegaer, Kelly M. Ricker, Joshua M. Hare

From the Department of Medicine (S.J.Z., G.G., G.O.R., K.V., K.M.R., J.M.H.), Cardiology Division, Johns Hopkins Medical Institutions, and Gerontology Research Center (E.G.L.), National Institute on Aging, Baltimore, Md.

Correspondence to Joshua M. Hare, MD, Cardiology Division, Johns Hopkins Hospital, 600 N Wolfe St, Carnegie 568, Baltimore, MD 21287-6568. E-mail jhare{at}mail.jhmi.edu

Abstract—Cardiovascular aging is associated with decreased endothelial vasoreactivity and prolonged diastolic relaxation. As diminished NO signaling contributes to age-associated endothelial dysfunction, we tested the hypothesis that impaired NO signaling or bioactivity also contributes to slowed ventricular relaxation with age. Accordingly, we measured myocardial NO synthase (NOS) enzyme activity, protein abundance, and cGMP production in old (22 to 25 months) and young adult (4 to 7 months) male Wistar rats. Both NOS3 protein abundance and calcium-dependent NOS activity were elevated in old compared with young adult hearts (7.2±1.1 versus 4.2±0.6 pmol/mg protein, respectively, P=0.03). However, NOS activity and protein abundance were similar in isolated myocytes, indicating that endothelial NOS likely explains the age difference. Cardiac effluent cGMP (enzyme immunoassay) was 4.8-fold higher (1794±373 fmol/min per mg heart tissue) in older versus younger hearts (P=0.003). To assess NO pathway responsiveness, we administered the NOS substrate l-arginine (100 µm) to isolated perfused rat hearts. Baseline isovolumic relaxation ({tau}) was prolonged in old (42.9±2.5 ms, n=16) versus young hearts (36.0±1.9 ms, n=11, P=0.03). l-Arginine decreased {tau} (P<0.001) and left ventricular end-diastolic pressure in both old and young hearts. Supporting an NO/cGMP-mediating mechanism, the NO donor sodium nitroprusside reduced {tau} (maximal effect, -14±2%, n=5, P<0.001), and this lusitropic effect was attenuated by the soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo-[4,3,-a]quinoxalin-1-one (n=7, P<0.001). Thus, the NO-cGMP pathway is upregulated in the endothelial cells of aged hearts. l-Arginine, the NOS precursor, enhances ventricular relaxation in old and young hearts, indicating that the NOS pathway may be exploited to modulate diastolic function in aged myocardium.


Key Words: aging • cGMP • nitric oxide synthase • diastole • l-arginine




This article has been cited by other articles:


Home page
EndocrinologyHome page
X. Xu, B. Sook Jhun, C. Hoon Ha, and Z.-G. Jin
Molecular Mechanisms of Ghrelin-Mediated Endothelial Nitric Oxide Synthase Activation
Endocrinology, August 1, 2008; 149(8): 4183 - 4192.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. R. White, S. Ryoo, D. Li, H. C. Champion, J. Steppan, D. Wang, D. Nyhan, A. A. Shoukas, J. M. Hare, and D. E. Berkowitz
Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats
Hypertension, February 1, 2006; 47(2): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
S. V. Y. Raju, L. A. Barouch, and J. M. Hare
Nitric Oxide and Oxidative Stress in Cardiovascular Aging
Sci. Aging Knowl. Environ., May 25, 2005; 2005(21): re4 - re4.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Willems, K. J. Ashton, and J. P. Headrick
Adenosine-mediated cardioprotection in the aging myocardium
Cardiovasc Res, May 1, 2005; 66(2): 245 - 255.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Berkowitz, R. White, D. Li, K. M. Minhas, A. Cernetich, S. Kim, S. Burke, A. A. Shoukas, D. Nyhan, H. C. Champion, et al.
Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels
Circulation, October 21, 2003; 108(16): 2000 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. P. Cappola, L. Cope, A. Cernetich, L. A. Barouch, K. Minhas, R. A. Irizarry, G. Parmigiani, S. Durrani, T. Lavoie, E. P. Hoffman, et al.
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy
Physiol Genomics, June 24, 2003; 14(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Chowdhary, G. A. Ng, S. L. Nuttall, and J. N. Townend
Upregulation of the Nitric Oxide-cGMP Pathway in Aged Myocardium
Circ. Res., March 16, 2001; 88 (5): e48 - e48.
[Full Text] [PDF]